SETD2 and neoplasm: These include the previously mentioned loss of function of the VHL tumor suppressor gene, inactivation of the SET domain containing protein 2 (SETD2), KDM6A, KDM5C – both lysine (K)-specific demethylases – and polybromo1 (PBRM1).